| Combinatorial drug screening identifies synergistic co-targeting of Bruton’s tyrosine kinase and the proteasome in mantle cell lymphoma M Axelrod, Z Ou, LK Brett, L Zhang, ER Lopez, AT Tamayo, V Gordon, ... Leukemia 28 (2), 407-410, 2014 | 54 | 2014 |
| Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma J Wang, J Wang, E Lopez, H Guo, H Zhang, Y Liu, Z Chen, S Huang, ... Blood cancer journal 9 (12), 95, 2019 | 22 | 2019 |
| Community-academic partnerships to promote health literacy and address social needs among low-income families during COVID-19 A Haidar, A Khoei, SE Alex, C Blick, E Lopez, S Wendt, R Ghanta, ... Journal of Nutrition Education and Behavior 53 (1), 75-78, 2021 | 17 | 2021 |
| Synthesis and characterization of a MoWC-WC-NiC nanocomposite via mechanical alloying and sintering JNR Olvera, GJG Paredes, AR Serrano, ER López, EM Franco, PT Meza, ... Powder technology 271, 292-300, 2015 | 15 | 2015 |
| Resistance mechanisms underlying venetoclax resistance in mantle cell lymphoma S Huang, C Jiang, H Guo, J Wang, Y Liu, C Li, E Lopez, H Zhang, ... Blood 130, 2749, 2017 | 8 | 2017 |
| Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma Q Cai, Y Chen, D Zou, L Zhang, M Badillo, S Zhou, E Lopez, W Jiang, ... Oncotarget 5 (17), 7368, 2014 | 7 | 2014 |
| Targeting BCR activated STAT3 by ibrutinib in mantle cell lymphoma Z Ou, LV Pham, MT Vang, L Zhang, J Wang, LM Strickland, ER Lopez, ... Blood 122 (21), 3079, 2013 | 6 | 2013 |
| Hospital use and mortality in transition-aged patients with sickle cell disease T Fasipe, D Dongarwar, E Lopez, R Brown, M Abadom, DH Mahoney, ... Hospital Pediatrics 11 (12), 1303-1310, 2021 | 5 | 2021 |
| drug screening reveals that ibrutinib (PCI-32765) exhibits synergy with BCL-2 and proteasome inhibitors in models of mantle cell lymphoma (MCL) and chronic lymphocytic leukemia … LK Brett, M Axelrod, Z Ou, L Zhang, V Gordon, ER Lopez, AT Tamayo, ... Blood 122 (21), 3080, 2013 | 5 | 2013 |
| FoxM1: a new therapeutic target for Mantle cell lymphoma H Guo, H Zhang, M Ahmed, Y Liu, S Huang, V Zhang, J Wang, E Lopez, ... Blood 130, 1469, 2017 | 2 | 2017 |
| Molecular pathways associated with ibrutinib resistance in mantle cell lymphoma L Zhang, K Nomie, S Zhang, Y Liu, H Guo, S Huang, J Wang, E Lopez, ... Blood 130, 2738, 2017 | 2 | 2017 |
| Carfilzomib, a second-generation proteasome inhibitor, in combination with the Btk inhibitor ibrutinib as a novel therapeutic regimen for treating double hit DLBCL EM Dominici, ER Lopez, MT Vang, AT Tamayo, Z Ou, A Rollo, L Zhang, ... Blood 122 (21), 1834, 2013 | 2 | 2013 |
| Novel combination of lenalidomide-rituximab provides an effective bridge to stem cell transplantation in relapsed and/or refractory aggressive B-cell non-Hodgkin's lymphomas: a … Q Cai, Y Chen, D Zou, M Badillo, S Zhou, L Zhang, ER Lopez, W Jiang, ... Blood 122 (21), 3056, 2013 | 2 | 2013 |
| Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets B Zhang, W Lewis, CA Stewart, BB Morris, LM Solis, A Serrano, Y Xi, ... JTO Clinical and Research Reports 5 (2), 100623, 2024 | 1 | 2024 |
| Disparities in mortality among acute myeloid leukemia‐related hospitalizations ST Alam, D Dongarwar, E Lopez, S Yellapragada, G Rivero, Q Huang, ... Cancer Medicine 12 (3), 3387-3394, 2023 | 1 | 2023 |
| Acute myeloid leukemia (AML) hospitalizations: racial disparity in outcomes of patients with comorbidities ST Alam, D Dongarwar, E Lopez, SV Yellapragada, G Rivero, ... Blood 138, 4135, 2021 | 1 | 2021 |
| Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients C Jiang, S Huang, Y Liu, C Li, H Guo, J Wang, E Lopez, H Zhang, ... Blood 130, 574, 2017 | 1 | 2017 |
| Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets B Zhang, W Lewis, CA Stewart, BB Morris, LM Solis, A Serrano, Y Xi, ... JTO Clinical and Research Reports 5 (2), 2024 | | 2024 |
| Disparities Among Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia E Lopez, D Dongarwar, MP Mims, ST Alam Blood 142, 5169, 2023 | | 2023 |
| The quality of advance care planning at a comprehensive cancer center. D Goyco Vera, ER Lopez, K Milligan, J Haro-Silerio, NA Patel, M Bilal, ... Journal of Clinical Oncology 41 (16_suppl), e18700-e18700, 2023 | | 2023 |
